4-Methyl-3-oxo-3,4-dihydro-quinoxaline-2-carboxylic acid, 95.0%, 5g

N-Boc-2-(2-amino-ethoxy)-ethylamine, 97.0%, 5g

3-Fluoropyridin-4-ol, 95.0%, 5g

Bismuth powder, min. 99.5%, approx. mesh, 100 g, glass packaging

3-(Piperidin-3-yl)propan-1-ol, 95.0%, 1g

1-Tosyl-1H-pyrazole, 95.0%, 25g

Ethyl 2-(2-aminoethyl)thiazole-4-carboxylate hydrochloride, 5g

Methyl 1-(azetidin-3-yl)-1H-pyrazole-4-carboxylate (trifluoroacetate), 1g

2,3-Diamino-5-chloropyridine, 98.0%, 5g

2,6-Diisopropylbenzaldehyde, 97%, 5g

3-Fluoro-2-nitrophenol>98.0%(GC)(T)5g

5-BROMO-1,3-BENZODIOXOL-4-AMINE, 95.0%, 100mg

METHYL 4-AMINOQUINOLINE-8-CARBOXYLATE HCL, 95.0%, 250mg